WAVE Life Sciences (WVE) Misses Q1 EPS by 22c

WAVE Life Sciences (NASDAQ: WVE) reported Q1 EPS of ($0.27), $0.22 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $12.9 million versus the consensus estimate of $38.6 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
• Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
• S&P 500 above 8,000 in 2026 now looks ambitious, Citi says